Investors Reassess Large Pharmaceutical Firms Amid Technological Shifts Investors are re-evaluating large pharmaceutical companies due to innovations in GLP-1, AI-driven drug discovery, and changing healthcare consumption patterns, according to VanEck. (Read More) Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Filed under: Altcoins - @ December 24, 2025 1:03 am